NCT04882644

Brief Summary

NAFLD is increasingly being identified in lean individuals, especially in Chinese population. Among the NAFLD patients, the lean NAFLD accounts for 15.9%-23.0%. Previous studies showed that the lean NAFLD individuals might have a higher risk of severe hepatic disease than those obese individuals. However, the effects of aerobic exercise on the reduction of liver fat content and metabolic risk factors in lean NAFLD individuals remain unknown. In this randomized controlled trial, we will examine the effect of a 3-month exercise training (aerobic exercise) on liver fat content and metabolic risk factors in lean NAFLD individuals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 28, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 12, 2021

Completed
2 days until next milestone

Study Start

First participant enrolled

May 14, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
Last Updated

September 20, 2024

Status Verified

September 1, 2024

Enrollment Period

1.4 years

First QC Date

April 28, 2021

Last Update Submit

September 18, 2024

Conditions

Keywords

Lean NAFLD

Outcome Measures

Primary Outcomes (1)

  • Changes from baseline in the liver fat content at 3 months after intervention.

    The magnetic resonance imaging-derived proton density fat fraction (MRI-PDFF) is used to detect the liver content. An diagnosis of NAFLD is the liver fat content \> 5%. Changes = (liver fat content at 3 months after intervention - liver fat content at baseline)

    3 months

Secondary Outcomes (12)

  • Changes from baseline in body mass index (BMI) at 3/12 months after intervention.

    3 months, 12 months

  • Changes from baseline in waist hip ratio(WHR) at 3/12 months after intervention.

    3 months, 12 months

  • Changes from baseline in abdominal fat at 3/12 months after intervention.

    3 months, 12 months

  • Changes from baseline in blood pressure at 3/12 months after intervention.

    3 months, 12 months

  • Changes from baseline in triglycerides at 3/12 months after intervention.

    3 months, 12 months

  • +7 more secondary outcomes

Study Arms (2)

Aerobic Exercise Intervention Group

EXPERIMENTAL

The subjects receive an intensive aerobic exercise for 3 months and a health education content for 12 months.

Behavioral: Aerobic Exercise

Control Group

NO INTERVENTION

The subjects do not change their physical activity routine and receive a health education content for 12 months.

Interventions

The subjects conduct an aerobic exercise at 65-80% maximum oxygen consumption three times per week for 60 min/session (including 5 min warm-up and 5 min cool down) with treadmills, ellipticals, and rowing machine. The subjects attend health education sessions (eg, general health knowledge of NAFLD and metabolic diseases, and elements of a healthy lifestyle) monthly in the 12 months.

Aerobic Exercise Intervention Group

Eligibility Criteria

Age30 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • \. Subjects with NAFLD determined by MRI-PDFF (liver fat\>5%).
  • \. Subjects with BMI\<23 kg/m2.
  • \. Subjects with inactive exercise before.
  • \. Subjects with basic abilities of understanding, communication and writing.

You may not qualify if:

  • \. Regular drinkers (consumed more than an average of 140 grams of ethanol per week in men and 70 grams in women during the past twelve months).
  • \. Complicated with other liver diseases (i.e. acute or chronic viral hepatitis, liver cancer, liver cirrhosis, drug-induced liver diseases, and autoimmune hepatitis).
  • \. Subjects with abnormal liver function (i.e. more than 3 times the upper limit of normal alanine aminotransferase and aspartate aminotransferase).
  • \. Complicated with severe cardiovascular disease \[i.e. myocardial infarction, arrhythmia, heart failure (New York Heart Association III or IV), uncontrolled hypertension (i.e. systolic blood pressure \>180 mmHg, and/or diastolic blood pressure \>100 mmHg)\].
  • \. Complicated with severe kidney disease or severe renal insufficiency or tumour.
  • \. Currently pregnant or planning to be pregnant or breast feeding women.
  • \. Participating in weight loss programs/exercise programs currently or during the past three months.
  • \. Having any medical condition that would affect metabolism or limit exercise (i.e. diabetes, known hyperthyroidism or hypothyroidism).
  • \. Having a medical condition that would limit exercise participation or alter heart rate during exercise or taking medication that would affect metabolism or weight loss (i.e. glucocorticoids, antithyroid drugs, hypoglycemic drugs, antihypertensive drugs).
  • \. Having been doing regular physical exercise for the past three months (i.e. 3 times/week, \>30 min/time).
  • \. Subjects with poor adherence.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital with Nanjing Medical University

Nanjing, China, 210029, China

Location

Related Publications (4)

  • Lee S, Bacha F, Hannon T, Kuk JL, Boesch C, Arslanian S. Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial. Diabetes. 2012 Nov;61(11):2787-95. doi: 10.2337/db12-0214. Epub 2012 Jun 29.

    PMID: 22751691BACKGROUND
  • Zhang HJ, He J, Pan LL, Ma ZM, Han CK, Chen CS, Chen Z, Han HW, Chen S, Sun Q, Zhang JF, Li ZB, Yang SY, Li XJ, Li XY. Effects of Moderate and Vigorous Exercise on Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial. JAMA Intern Med. 2016 Aug 1;176(8):1074-82. doi: 10.1001/jamainternmed.2016.3202.

    PMID: 27379904BACKGROUND
  • Houghton D, Thoma C, Hallsworth K, Cassidy S, Hardy T, Burt AD, Tiniakos D, Hollingsworth KG, Taylor R, Day CP, McPherson S, Anstee QM, Trenell MI. Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2017 Jan;15(1):96-102.e3. doi: 10.1016/j.cgh.2016.07.031. Epub 2016 Aug 10.

    PMID: 27521509BACKGROUND
  • Kistler KD, Brunt EM, Clark JM, Diehl AM, Sallis JF, Schwimmer JB; NASH CRN Research Group. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol. 2011 Mar;106(3):460-8; quiz 469. doi: 10.1038/ajg.2010.488. Epub 2011 Jan 4.

    PMID: 21206486BACKGROUND

MeSH Terms

Conditions

Non-alcoholic Fatty Liver Disease

Interventions

Exercise

Condition Hierarchy (Ancestors)

Fatty LiverLiver DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Qun Zhang, Professor

    The First Affiliated Hospital with Nanjing Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 28, 2021

First Posted

May 12, 2021

Study Start

May 14, 2021

Primary Completion

September 30, 2022

Study Completion

September 30, 2022

Last Updated

September 20, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations